pills

Healthcare DECODED

Previous edition: 06 May 2024
Share article

Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now

Alberta government commits $10m to enhance women's healthcare

The investment will create additional treatment spaces and expand current health programmes.

The Calgary Health Foundation, a non-profit organisation, has announced a $10m investment from the Alberta Government in Canada to bolster efforts on women's healthcare.

This two-year commitment is poised to make a substantial impact on healthcare for women across southern Alberta.

The one-time funding aims to mitigate gender inequality in healthcare, encompassing research, policy, and clinical practice.

In addition to leading to shorter wait times for women's health services, the investment is expected to create additional examination and treatment spaces, and the expansion of current health programmes.

The Government of Alberta's investment seeks to address the fact that Alberta falls below the national average for medical research funding dedicated to women's health, which is currently at 8%.

Calgary Health Foundation president and CEO Murray Sigler said: “This investment will enable us to give the necessary attention, funding, and advocacy to the unique health challenges of women.

“Through partnerships like the one with Dr Erin Brennand and the Calgary Pelvic Floor Clinic, the funding will allow us to confront the gaps in the diagnosis, treatment, and care of women's health concerns.”

As per a 2021 Alberta Women’s Health Foundation (AWHF) report, even though women constituted 51% of the province’s population, just 3.4% of its total research funds were allocated to female-specific health issues.

The latest $10m investment is anticipated to shift the balance in favour of women's health research and outcomes.

Health Minister Adriana LaGrange said: “These investments will make a real difference in tackling health issues that impact women, promoting overall well-being, and ensuring every Albertan can thrive, no matter their age or stage in life.”

Latest news

Ireland's Mayo University Hospital announces ED expansion plans

The project involves constructing a two-storey extension, with the ED on the ground floor and the AMAU above it.

Intermountain Health using Nuance Communications AI solutions

The DAX Copilot platform is designed to automate clinical documentation and administrative tasks.

Swire Pacific acquires controlling stake in DeltaHealth

The acquisition is part of Swire Pacific's strategy to be a long-term owner and operator of healthcare services.

Bunya Day Surgery opens to patients in Queensland, Australia

The facility is equipped to perform simple procedures that eliminate the need for overnight hospital stays.

Biohaven's Taldefgrobep alfa could target broad SMA patients

Biohaven Ltd. announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for taldefgrobep alfa, a novel anti-myostatin adnectin, for the treatment of spinal muscular atrophy (SMA). Fast Track designation enables important new drugs to reach patients earlier by facilitating more frequent communications with the FDA and expeditious review of a drug which treats a serious condition and fills an unmet medical need. Biohaven previously received orphan drug designation from the FDA for taldefgrobep in the treatment of SMA.

PTCA Drug Coated Balloon (DCB) Catheters Pipeline

Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development.

See a Sample

Newsletters in other sectors

Aerospace, Defence & Security

Lithuanian Defence Minister coaxes US defence investment
06 May 2024

Explore our market-leading Intelligence Centers

Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries

Explorer

Access more premium companies when you subscribe to Explorer